Skip to main content
OpenTrials

Clinical trial condition

Dermatitis

Explore clinical trials studying Dermatitis. Study availability and eligibility vary by location and protocol.

1,525 public trials 180 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis trial results

Completed

A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04501679

Conditions
Dermatitis, Neurodermatitis, Pathological Conditions, Signs and Symptoms, +8 more
Locations
  • Galderma Investigational Site Fountain Valley, California, United States
  • Galderma Investigational Site San Diego, California, United States
  • Galderma Investigational Site Washington D.C., District of Columbia, United States
  • Galderma Investigational Site Aventura, Florida, United States
View all 74 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04501666

Conditions
Dermatitis, Neurodermatitis, Pathological Conditions, Signs and Symptoms, +8 more
Locations
  • Galderma Investigational Site Birmingham, Alabama, United States
  • Galderma Investigational Site Birmingham, Alabama, United States
  • Galderma Investigational Site Los Angeles, California, United States
  • Galderma Investigational Site Sacramento, California, United States
View all 100 locations
View Trial Details
Completed

Effect of Lipikar Baume AP+M on Quality of Life and Pain of Adults With Dryness or Severe Xerosis

NCT05765461

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Dermatology practices Zagreb, Croatia
  • Dermatology practices Berlin, Germany
  • Dermatology practices Lisbon, Portugal
  • Dermatology practices Pretoria, South Africa
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.

NCT04836858

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Novartis Investigative Site Pardubice, Czech Republic, Czechia
  • Novartis Investigative Site Prague, Czechia
  • Novartis Investigative Site Marseille, France
  • Novartis Investigative Site Nice, France
View all 18 locations
View Trial Details
Completed

Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

NCT02651714

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Vanda Investigational Site Encinitas, California, United States
  • Vanda Investigational Site Encino, California, United States
  • Vanda Investigational Site Lomita, California, United States
  • Vanda Investigational Site San Diego, California, United States
View all 28 locations
View Trial Details

Related conditions